Claims
- 1. A method of administering a preparation containing a physiologically active peptide to a patient in need thereof, wherein the preparation comprises a physiologically active peptide, a sucrose fatty acid ester and an organic acid which is selected from the group consisting of malic acid, lactic acid and citric acid, or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable carrier or diluent, and which preparation has a pH value of 3 to 7; said method comprising administering the preparation to the patient intravaginally.
- 2. The method according to claim 1, wherein the organic acid is citric acid.
Priority Claims (1)
Number |
Date |
Country |
Kind |
5-135738 |
Jun 1993 |
JPX |
|
Parent Case Info
This application is divisional of application Ser. No. 08/557,104, filed on Dec. 6, 1995, now U.S. Pat. No. 5,776,886. Application Ser. No. 08/557,104 is the national phase of PCT International Application No. PCT/JP94/00894 filed on Jun. 2, 1994 under 35 U.S.C. .sctn. 371. The entire contents of each of the above identified applications are hereby incorporated by reference.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5482706 |
Igari et al. |
Jan 1996 |
|
5776886 |
Inamoto et al. |
Jul 1998 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
517211 |
Dec 1992 |
EPX |
Non-Patent Literature Citations (1)
Entry |
Remington's Pharmaceutical Sciences, 18th Ed., pp. 245-246 (1990). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
557104 |
|
|